Citra Nusantara Gemilang Tbk. vs Kalbe Farma Tbk — how do they compare? Citra Nusantara Gemilang Tbk. trades at Rp149 (market cap 267.5B, 1.18M 24h volume), while Kalbe Farma Tbk trades at Rp800 (market cap 37.45T, 41.79M 24h volume). The key difference: Kalbe Farma Tbk is far larger — about 140× Citra Nusantara Gemilang Tbk.'s market cap, and Kalbe Farma Tbk is more actively traded (41.79M versus 1.18M). Which is the better fit depends on your goals.
| CGAS | KLBF | |
|---|---|---|
Market Cap | 267.5B | 37.45T |
Volume | 1.18M | 41.79M |
Lot | 11.84K | 417.89K |
Turnover | 177.38M | 33.46B |
Average Price | 149.88 | 800.79 |
Value | 177.38M | 33.46B |
Indicative Equilibrium Price | 149 | 800 |
Indicative Equilibrium Volume | 432 | 18.3K |
Trailing returns across standard periods
Latest headlines on both assets
PT Citra Nusantara Gemilang Tbk (the “Company”), was established based on Notarial Deed No. 22, dated December 21, 2005 of Edi Priyono, S.H.. The Company's parent entity is PT Petro Asia Energy
Read more on CGAS →PT Kalbe Farma Tbk (the Company) was established in the Republic of Indonesia, within the framework of the Domestic Capital Investment Law No. 6 Year 1968, as amended by Law No. 12 Year 1970, basedon Notarial Deed No. 3 of Raden Imam Soesetyo Prawirokoesoemo datedon September 10th, 1966. The Company, which started commercial operation in 1966.
Read more on KLBF →